NFKB1 and colorectal carcinoma: Regarding to CRC, CGA could suppress the viability and migration of cancer cells by promoting ROS production, reducing miR-31 oncogene, arresting the cell cycle, suppressing NF-κB pathways and increasing cytotoxicity (47–49).